Capital World Investors Argenx Se Transaction History

Capital World Investors

$625 Billion
Q3 2024

A detailed history of Capital World Investors transactions in Argenx Se stock. As of the latest transaction made, Capital World Investors holds 1,700,249 shares of ARGX stock, worth $1.09 Billion. This represents 0.15% of its overall portfolio holdings.

Number of Shares

1,700,249

Previous 1,511,494 12.49%

Holding current value

$1.09 Billion

Previous $650 Million 41.86%

% of portfolio

0.15%

Previous 0.11%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$434.22 - $551.9 $82 Million - $104 Million	188,755 Added 12.49%	1,700,249 $922 Million
Q2 2024 Aug 13, 2024	SELL	$356.01 - $451.55 $126 Million - $159 Million	-353,102 Reduced 18.94%	1,511,494 $650 Million
Q1 2024 May 14, 2024	SELL	$356.95 - $413.29 $34.5 Million - $39.9 Million	-96,606 Reduced 4.93%	1,864,596 $734 Million
Q4 2023 Feb 13, 2024	BUY	$338.91 - $506.01 $180 Million - $268 Million	530,181 Added 37.05%	1,961,202 $746 Million
Q3 2023 Nov 13, 2023	BUY	$369.35 - $548.43 $91.8 Million - $136 Million	248,572 Added 21.02%	1,431,021 $704 Million
Q2 2023 Aug 11, 2023	BUY	$360.14 - $422.58 $45 Million - $52.8 Million	124,953 Added 11.82%	1,182,449 $461 Million
Q1 2023 May 15, 2023	BUY	$334.23 - $403.65 $106 Million - $128 Million	316,562 Added 42.72%	1,057,496 $394 Million
Q4 2022 Feb 14, 2023	BUY	$342.17 - $402.31 $320,271 - $376,562	936 Added 0.13%	740,934 $281 Million
Q3 2022 Nov 14, 2022	BUY	$343.2 - $395.75 $207,979 - $239,824	606 Added 0.08%	739,998 $261 Million
Q1 2022 May 16, 2022	BUY	$254.45 - $351.06 $20.1 Million - $27.8 Million	79,119 Added 11.98%	739,392 $233 Million
Q4 2021 Feb 14, 2022	SELL	$272.01 - $353.03 $85,411 - $110,851	-314 Reduced 0.05%	660,273 $231 Million
Q3 2021 Nov 15, 2021	SELL	$295.0 - $350.58 $96,760 - $114,990	-328 Reduced 0.05%	660,587 $199 Million
Q2 2021 Aug 16, 2021	SELL	$257.11 - $319.92 $283,849 - $353,191	-1,104 Reduced 0.17%	660,915 $199 Million
Q1 2021 May 14, 2021	BUY	$268.3 - $380.31 $101,954 - $144,517	380 Added 0.06%	662,019 $182 Million
Q3 2020 Nov 13, 2020	BUY	$215.51 - $272.51 $7,111 - $8,992	33 Added 0.0%	661,639 $174 Million
Q2 2020 Aug 14, 2020	BUY	$127.44 - $232.72 $10.8 Million - $19.7 Million	84,863 Added 14.71%	661,606 $149 Million
Q1 2020 May 15, 2020	BUY	$108.83 - $165.23 $2,394 - $3,635	22 Added 0.0%	576,743 $76 Million
Q4 2019 Feb 18, 2020	BUY	$106.59 - $164.21 $13.8 Million - $21.3 Million	129,588 Added 28.98%	576,721 $92.6 Million
Q3 2019 Nov 14, 2019	BUY	$113.31 - $150.51 $24.6 Million - $32.7 Million	217,097 Added 94.38%	447,133 $51 Million
Q2 2019 Aug 14, 2019	BUY	$115.0 - $141.58 $2.04 Million - $2.51 Million	17,736 Added 8.35%	230,036 $32.6 Million
Q1 2019 May 15, 2019	BUY	$98.85 - $134.59 $21 Million - $28.6 Million	212,300 New	212,300 $26.5 Million

Others Institutions Holding ARGX

# of Institutions

401

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $35.3B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.

Account

Capital World Investors Argenx Se Transaction History